NEXT Oncology — Fairfax, Virginia

NEXT Oncology is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Clinical Trials Trust Score: 30/100 (FAILING). This profile has not yet been claimed by the site owner.

NEXT Oncology has participated in 97 clinical trials with 76 currently active.

Therapeutic areas: RAS Mutation, NF1 Mutation, RAF Mutation.

Sponsors: Pasithea Therapeutics Corp., EMD Serono Research & Development Institute, Inc., Astellas Pharma Global Development, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

Sponsor Feasibility Report

Trust Score: 30/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT Oncology?

NEXT Oncology has a Crixeo Trust Score of 30/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT Oncology conducted?

NEXT Oncology has 97 clinical trials on record, with 76 currently active. Their work covers RAS Mutation, NF1 Mutation, RAF Mutation.

Is NEXT Oncology accredited by Crixeo Clinical Trials?

NEXT Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.